Its subsidiary, Escalon Vascular Access, plans to commence shipments of the product in the US immediately.
Richard DePiano Jr, president of Escalon Medical, said: “The clearance of the VascuView system is a very promising milestone as it not only reflects the successful culmination of our R&D efforts but represents our third FDA market clearance in the last six weeks.”